Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How do you approach treatment of a glioblastoma in pregnancy?

2
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Louisville School of Medicine

Glioblastoma during pregnancy could be treated safely (to mother and fetus) with certain precautions and modifications. Collaboration and consultation with the patient’s obstetrician are essential. External shielding over the patient’s abdomen during treatment will decrease the external scatter radi...

Would you offer hypofractionated radiation regimens for a young patient with glioblastoma with good performance status but travel concerns, making 6 weeks of radiation difficult?

3
6 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

I am not a neuro-radiation oncologist, but I must register my disagreement with Dr. @Dr. First Last answer. This is GBM. The cure rate is exceedingly low, no matter what the fractionation, age of the patient, PS, etc. We should work with the patient to maximize their remaining quality of life and no...

How do you interpret recent large retrospective analyses comparing radical prostatectomy vs. radiation for prostate cancer?

13
8 Answers

Mednet Member
Mednet Member
Radiation Oncology

There have been numerous comparisons of RT vs. RP from a variety of study teams with various conclusions, and it often seems like the principal conclusion of the study is best predicted by the subspecialty from which the authors originated (urology vs. radiation oncology). As the question partially ...

When should you use single-fraction radiotherapy for spinal cord compression?

14
5 Answers

Mednet Member
Mednet Member
Radiation Oncology · Rochester Regional Health Aco Inc

The SCORAD III trial is practice changing. But I do NOT plan to treat ALL patients with spinal cord compression with a single fraction of 8 Gy now. Here is why: SCORAD III is extremely important new study for the management of metastatic epidural spinal cord compression (MESCC) for patients with sho...

How do you approach the decision to boost patients diagnosed with DCIS?

2
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Based on prospective and also retrospective data Chua, AACR Volume 81, Issue 4 Supplement, pp. GS2-04. We would recommend for high grade, < 50 years and close margin and in the era of genomic testing to patients with high genomic score.

How would you approach a radiation-induced angiosarcoma of the breast after mastectomy with negative margins?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Based on this research we tend to offer RT for high grade or tumor more than 5 cm or RT induced; there is no good prospective data. Based on UF series, we offer accelerated hyperfractionation 1.5 BID to 45 to 50 Gy, treating only chest wall.

What measures should we take regarding routine follow-up visits for well patients in surveillance during the coronavirus pandemic?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Meadowview Regional Medical Center

3-6 months.

Is long term ADT now the standard of care with salvage prostate bed RT?

34
7 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Utah School of Medicine

The dreaded hormone question...After 40 years of embarking on extremely well designed randomized trials, we still are confused about the who, what, when of ADT. Will RTOG 9601 create a new care standard? As @Dr. First Last said, I think we will see increased utilization. I have been using bicalutami...

Does non-urothelial histology impact your approach to chemoradiotherapy for muscle-invasive bladder cancer?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · West Virginia University Hospitals

There is no randomized data available in this regard to guide us through non-urothelial histologies for MIBC. However, certain points that are worth considering in their management are: For small cell or neuroendocrine tumors, cisplatin/etoposide or ifosfamide/doxorubicin-based systemic therapy in ...

What is the optimal duration of ADT in high-risk prostate cancer treated with RT+ADT?

18
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · Cedars-Sinai Medical Center

Nabib et al. presented "Final Results" of the 18 vs. 36 month ADT trial for high-risk M0 prostate cancer in Chicago during ASCO 2017. This trial has the potential to be practice changing, since most men receive 2+ years of ADT during RT-ADT for high-risk disease. 630 patients were randomized and OS ...